Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

DOJ Vs. Anheuser-Busch InBev NV (BUD)

Page 1 of 2

After working for over a year for Anheuser-Busch InBev NV (NYSE:BUD) I realized not only how good the company was for making acquisitions and cutting costs but also how smart it was at using its high share of the market to increase prices. The company’s results speak for itself, its EBITDA margin is 39%. Such great profitability is achieved through dominant market position in many of the markets where the company operates (such as Brazil or Argentina). In those markets, the company can achieve better pricing and lower fixed costs per hectoliter than its competitors. If AB InBev had the same market dominance in the US as in Brazil or Argentina, then the company would be one of the most efficient cash machines in corporate history.

Anheuser-Busch InBev NV (ADR) (NYSE:BUD)

Thinking of all the above, I do realize that the Department of Justice (DOJ) had a point when it launched a legal challenge to BUD’s proposed acquisition of Grupo Modelo, owner of Corona and other brands. Clearly, the challenge is largely based on beer prices. The DOJ says Modelo, by refusing to follow BUD’s lead in pushing up US prices, has helped keep the market competitive. Raising beer prices is great for the industry and bad for consumers but competitors are also worried. In their case the cause for concern is related to the increased distribution difficulties that they may suffer if AB InBev would dominate the market; after all, beer is mainly a distribution business and the company has a history of blocking competitors around the globe.

When DOJ’s allegations were filtered to the press, share prices fell for everyone involved in the deal. AB InBev and Modelo dropped 8% and Constellation Brands, Inc. (NYSE:STZ) (which would have gained full control of the joint venture that distributes Modelo’s brands in the US, had the deal gone through) lost more than 17%.

AB Inbev has three options.

(1) It could take on the mighty DOJ. They had hoped to persuade the authorities that Constellation, as the sole distributor of Modelo’s beer, would have control over pricing. The DOJ disagreed but the judges might not. An army of lawyers will no doubt earn a large fee for trying to persuade them.

(2) The company could change the deal to smooth the DOJ’s concerns. This is possible, but it will not come without economic and strategic consequences. For example, BUD could potentially offer to sell production facilities in Mexico and the distribution venture in the US. That said, the US accounts for about a quarter of Modelo’s revenues, so getting rid of the entire US business would become seemingly expensive at the deal’s current valuation.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!